Narayana Hrudayalaya – Q2 FY18 Consolidated operating income at Rs 5,592 mn (y-o-y of 14.7%) with EBITDA of Rs 638 mn

H1 FY18 Consolidated operating income at Rs 10,803 mn (y-o-y of 15.0%) with EBITDA of Rs 1,194 mn

Bengaluru, November 08, 2017: Narayana Hrudayalaya Limited, a leading healthcare service provider in India, today announced its financial results for the second quarter (Q2 FY18) and six months (H1 FY18) ended September 30th, 2017. 

Financial Highlights for the Quarter (Q2 FY18) – Prepared in accordance with Ind AS (‘Indian Accounting Standards’)

▪ Consolidated total operating income was Rs 5,592 mn for Q2 FY18 as compared to Rs 4,874 mn in the corresponding period of the previous year, reflecting an increase of 14.7%

▪ Consolidated EBITDA stood at Rs 638 mn, reflecting a margin of 11.4% as against Rs 681 mn in Q2 FY17

▪ PAT after minority interest and share of loss in associates stood at Rs 165 mn as compared to Rs 265 mn in Q2 FY17 

Financial Highlights for the Six Months (H1 FY18) 

▪ Consolidated total operating income was Rs 10,803 mn for H1 FY18 as compared to Rs 9,394 mn in the corresponding period of the previous year, reflecting an increase of 15.0%

▪ Consolidated EBITDA stood at Rs 1,194 mn, reflecting a margin of 11.1% as against Rs 1,240 mn in H1 FY17

▪ PAT after minority interest and share of loss in associates stood at Rs 275 mn as compared to Rs 437 mn in H1 FY17

As on September 30th, 2017, the consolidated net debt was Rs 3,375 mn representing a net debt to equity ratio of 0.34

Other Highlights during the Quarter

▪ Our superspeciality hospital at Vaishno Devi, Jammu performed its 5,000th dialysis in August 2017 (17th month of operations) cementing the facility’s pre-eminence in nephrology in the northern region of the country

▪ Our hospital in Mumbai successfully performed Extracorporeal Membrane Oxygenation (ECMO) on a little girl suffering from H1N1 and severe hypoxemic respiratory failure, the procedure being first of its kind in a paediatric case in Mumbai

▪ For the first time in Eastern India, a patient was successfully treated with Flattering Filter-Free Radiotherapy in Narayana Superspeciality Hospital, Howrah bolstering our reputation as a leading player in oncology

▪ Our hospital in Howrah successfully performed a complicated procedure involving Intra-Cardiac Repair for Tetralogy of Fallot along with a complete chest wall reconstruction on a 2-year-old girl

▪ NH won The Economic Times “The Best Asian Healthcare Brands 2017” award and “The Express Healthcare Excellence Award 2017” in Health Tourism category in September 2017

▪ Our SRCC Children’s Hospital won “The Best Emerging Brand” award at the National Award for Marketing Excellence presented by Times Network in September 2017

Management Comment

Commenting on the performance, Dr. Ashutosh Raghuvanshi, Vice Chairman, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said “First quarter of fiscal 2018, despite being hit by regulatory challenges, witnessed a strong growth in revenues and we are pleased to report that the second quarter continued with the strong momentum generated in Q1 FY18. Results in this quarter are in accordance with our expectations taking into consideration the typical maturity cycle a newly commissioned hospital like our Mumbai facility experiences in its initial phase of operations. We remain confident about the long-term prospects of our business and committed towards the growth trajectory NH has charted upon.”

Corporate Comm India(CCI Newswire)